Grasso S, Chimirri A, Monforte P, Fenech G, Zappalà M
Farmaco Sci. 1986 Sep;41(9):713-21.
Some 1-aryl-N,N'-di-[2-(1,3,4-thiadiazolyl)]methylendiamines were synthetized and tested against lymphocytic murine leukemia P 388. Compounds (I)-(III), (VIII)-(XII) and (XVIII)-(XIX) showed significant by prolongation the survival time of tumor-bearing mice (T/C% 129-194).
合成了一些1-芳基-N,N'-二-[2-(1,3,4-噻二唑基)]亚甲基二胺,并对其进行了抗小鼠淋巴细胞白血病P 388的测试。化合物(I)-(III)、(VIII)-(XII)和(XVIII)-(XIX)通过延长荷瘤小鼠的存活时间显示出显著效果(T/C%为129 - 194)。